Skip to main content
. 2012 Nov 7;24(3):618–624. doi: 10.1093/annonc/mds512

Figure 1.

Figure 1.

Changes in treatment recommendations: black squares, chemoendocrine therapy (CHT); dark gray squares, chemotherapy; very light gray squares, endocrine therapy only (HT); light gray squares, observation.